|
|
Elizabeta Nemeth, Seth Rivera, Victoria Gabayan, Charlotte Keller, Sarah Taudorf, Bente K. Pedersen, Tomas Ganz
J Clin Invest. 2004;
113(9):1271
doi:10.1172/JCI20945
Abstract |
Full text
| PDF
H
ypoferremia is a common response to systemic infections or generalized inflammatory disorders. In mouse models, the development of hypoferremia during inflammation requires hepcidin, an iron regulatory peptide hormone produced in the liver, but the inflammatory signals that regulate hepcidin are largely unknown. Our studies in human liver cell cultures, mice, and human volunteers indicate that IL-6 is the necessary and sufficient cytokine for the induction of hepcidin during inflammation and that the IL-6–hepcidin axis is responsible for the hypoferremia of inflammation.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(138)
| Title and authors |
Publication |
Year |
IL-6/IL-6 receptor system and its role in physiological and pathological conditions
Masahiko Mihara, Misato Hashizume, Hiroto Yoshida, Miho Suzuki, Masashi Shiina
|
Clin. Sci.
|
2012 |
Iron Overload in Human Disease
Robert E. Fleming, Prem Ponka
|
N Engl J Med
|
2012 |
Hepcidin and iron regulation, 10 years later
T. Ganz
|
Blood
|
2011 |
Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation
A. U. Steinbicker, C. Sachidanandan, A. J. Vonner, R. Z. Yusuf, D. Y. Deng, C. S. Lai, K. M. Rauwerdink, J. C. Winn, B. Saez, C. M. Cook, B. A. Szekely, C. N. Roy, J. S. Seehra, G. D. Cuny, D. T. Scadden, R. T. Peterson, K. D. Bloch, P. B. Yu
|
Blood
|
2011 |
Hepcidin: clinical utility as a diagnostic tool and therapeutic target
Daniel W Coyne
|
Kidney Int
|
2011 |
The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia
Palle Bager, Ragnar Befrits, Ola Wikman, Stefan Lindgren, Bjørn Moum, Henrik Hjortswang, Jens F. Dahlerup
|
Scand J Gastroenterol
|
2011 |
The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
Misato Hashizume, Masahiko Mihara
|
Arthritis
|
2011 |
Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses
Z. Zhang, F. Zhang, P. An, X. Guo, Y. Shen, Y. Tao, Q. Wu, Y. Zhang, Y. Yu, B. Ning, G. Nie, M. D. Knutson, G. J. Anderson, F. Wang
|
Blood
|
2011 |
Anemia of Chronic Disease in Chronic Obstructive Pulmonary Disease: A Case-Control Study of Cardiopulmonary Exercise Responses
Afroditi K. Boutou, Ioannis Stanopoulos, Georgia G. Pitsiou, Theodoros Kontakiotis, George Kyriazis, Lazaros Sichletidis, Paraskevi Argyropoulou
|
Respiration
|
2011 |
Serum hepcidin: reference ranges and biochemical correlates in the general population
T. E. Galesloot, S. H. Vermeulen, A. J. Geurts-Moespot, S. M. Klaver, J. J. Kroot, D. van Tienoven, J. F. M. Wetzels, L. A. L. M. Kiemeney, F. C. Sweep, M. den Heijer, D. W. Swinkels
|
Blood
|
2011 |
|